- Home
- CYN vs EKSO Comparison
CYN vs EKSO Comparison
Compare CYN & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYN
- EKSO
- Stock Information
- Founded
- CYN 2013
- EKSO 2005
- Country
- CYN United States
- EKSO United States
- Employees
- CYN 81
- EKSO N/A
- Industry
- CYN EDP Services
- EKSO Medical/Dental Instruments
- Sector
- CYN Technology
- EKSO Health Care
- Exchange
- CYN Nasdaq
- EKSO Nasdaq
- Market Cap
- CYN 2.2M
- EKSO 13.4M
- IPO Year
- CYN 2021
- EKSO N/A
- Fundamental
- Price
- CYN $0.08
- EKSO $0.55
- Analyst Decision
- CYN
- EKSO Strong Buy
- Analyst Count
- CYN 0
- EKSO 2
- Target Price
- CYN N/A
- EKSO $5.50
- AVG Volume (30 Days)
- CYN 14.2M
- EKSO 2.9M
- Earning Date
- CYN 03-05-2025
- EKSO 03-03-2025
- Dividend Yield
- CYN N/A
- EKSO N/A
- EPS Growth
- CYN N/A
- EKSO N/A
- EPS
- CYN N/A
- EKSO N/A
- Revenue
- CYN $102,118.00
- EKSO $17,682,000.00
- Revenue This Year
- CYN $18.11
- EKSO N/A
- Revenue Next Year
- CYN $198.58
- EKSO $32.74
- P/E Ratio
- CYN N/A
- EKSO N/A
- Revenue Growth
- CYN N/A
- EKSO 4.12
- 52 Week Low
- CYN $0.07
- EKSO $0.47
- 52 Week High
- CYN $25.90
- EKSO $2.32
- Technical
- Relative Strength Index (RSI)
- CYN 22.03
- EKSO 36.46
- Support Level
- CYN $0.50
- EKSO $0.47
- Resistance Level
- CYN $0.63
- EKSO $0.67
- Average True Range (ATR)
- CYN 0.07
- EKSO 0.06
- MACD
- CYN 0.09
- EKSO -0.01
- Stochastic Oscillator
- CYN 0.07
- EKSO 22.90
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.